Multivalent anthelminthic vaccine to prevent hookworm and schistosomiasis

Expert Review of Vaccines

Volumn 7, Issue 6, 2008, Pages 745-752

  Hotez, Peter J ^a   Bethony, Jeffrey M ^a,b   Oliveira, Sergio Costa ^c   Brindley, Paul J ^a   Loukas, Alex ^d  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^d QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

Anemia; Hookworm infection; Necator americanus; Schistosoma; Schistosomiasis; Vaccine

Indexed keywords

ANTHELMINTIC AGENT; HOOKWORM VACCINE; SCHISTOSOMA VACCINE; UNCLASSIFIED DRUG; VACCINE;

GEOGRAPHIC DISTRIBUTION; HOOKWORM INFECTION; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; MORBIDITY; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; REINFECTION; REVIEW; SCHISTOSOMIASIS; VACCINATION;

AFRICA SOUTH OF THE SAHARA; ANCYLOSTOMATOIDEA; ANIMALS; ASIA; BRAZIL; HOOKWORM INFECTIONS; HUMANS; SCHISTOSOMA; SCHISTOSOMIASIS; VACCINES;

EID: 49449092450     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/14760584.7.6.745     Document Type: Review

References (45)

1. Hotez PJ, Brindley PJ, Bethony JM, King CH, Pearce EJ, Jacobson J. Helminth infections: the great neglected tropical diseases. J. Clin. Invest. 118(4), 1311-1321 (2008). • Summarizes the global impact of helminth infections and targets for drug and vaccine interventions.
2. Hotez PJ, Molyneux DH, Fenwick A, Ottesen E, Ehrlich Sachs S, Sachs JD. Incorporating a rapid-impact package for neglected tropical diseases with programs for HIV/AIDS, tuberculosis, malaria. PLoS Med. 3(5), e102 (2006). • Summarizes how helminth infections contribute to morbidities of malaria and HIV/AIDS.
3. De Silva NR, Brooker S, Hotez PJ, Montresor A, Engles D, Savioli L. Soil-transmitted helminth infections: updating the global picture. Trends Parasitol. 19(12), 547-551 (2003).
4. Bethony J, Brooker S, Albonico M et al. Soil-transmitted helminth infections: ascariasis, trichuriasis, and hookworm. Lancet 367(9521), 1521-1532 (2006). • Summarizes the global impact of hookworm and other soil-transmitted helminth infections.
5. Stoltzfus RJ, Dreyfuss ML, Chwaya HM, Albonico M. Hookworm control as a strategy to prevent iron deficiency. Nutr. Rev. 55(6), 223-232 (1997). • Summarizes the impact of hookworm infection on global anemia.
6. Bleakley H. Disease and development: evidence from hookworm eradication in the American South. Q. J. Economics 122(1), 73-117 (2007).
7. Steinmann P, Keiser J, Bos R, Tanner M, Utzinger J. Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk. Lancet Infect. Dis. 6(7), 411-425 (2006).
8. van der Werf MJ, de Vlas SJ, Brooker S et al. Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa. Acta Trop. 86(2-3), 125-139 (2003).
9. Friedman JF, Kanzaria HK, McGarvey ST. Human schistosomiasis and anemia: the relationship and potential mechanisms. Trends Parasitol. 21(8), 386-392 (2005). • Highlights the role of schistosomiasis in eliciting anemia.
10. King CH, Dickman K, Tisch DJ. Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis. Lancet 365(9470), 1561-1569 (2005). • Summarizes the underappreciated disease burden of schistosomiasis.
11. Chan MS. The global burden of intestinal nematode infections - fifty years on. Parasitol. Today 13(11), 438-445 (1997).
12. World Health Organization. Annex tables 2 and 3. In: World Health Report 2004: Changing History. World Health Organization, Geneva, Switzerland 120-127 (2004).
13. Finkelstein JL, Schleinitz MD, Carabin H, McGarvey ST. Decision-model estimation of the age-specific disability weight for schistosomiasis japonica: a systematic review of the literature. PLoS Negl. Trop. Dis. 2(3), e158 (2008).
14. Hotez P. Hookworm and poverty. Ann. NY Acad. Sci. DOI: 10.1196 (2008) (Epub ahead of print).
15. Asaolu SO, Ofoezie LE. The role of health education and sanitation in the control of helminth infections. Acta Trop. 86(2-3), 283-294 (2003).
16. Moraes LRS, Azevedo Cancio J, Cairncross S. Impact of drainage and sewerage on intestinal nematode infections in poor urban areas in Salvador, Brazil. Trans. R. Soc. Trop. Med. 98 (4), 197-204 (2004).
17. Stoltzfus RJ, Kvalsvig JD, Chwaya HM et al. Effect of iron supplementation and anthelminthic treatment on motor and language development of preschool children in Zanzibar: double blind, placebo, controlled study. BMJ 323, 1389-1393 (2001).
18. Singer BH, de Castro MC. Bridges to sustainable tropical health. Proc. Natl Acad. Sci. USA 104(41), 16038-16043 (2007).
19. Fenwick A, Rollinson D, Southgate V. Implementation of human schistosomiasis control: challenges and prospects. Adv. Parasitol. 61, 567-622 (2006).
20. Diemert DJ, Bethony JM, Hotez PJ. Hookworm vaccines. Clin. Infect. Dis. 46(2), 282-288 (2008). •• Summarizes many of the leading candidate hookworm antigens.
21. McManus DP, Loukas A. Current status of vaccines for schistosomiasis. Clin. Microbiol. Rev. 21(1), 225-242 (2008). •• Summarizes many of the leading candidate schistosome antigens.
22. Agnew A, Fulford AJ, Mwanje MT et al. Age-dependent reduction of schistosome fecundity in Schistosoma haematobium but not Schistosoma mansoni infections in humans. Am. J. Trop. Med. Hyg. 55(3), 338-343 (1996).
23. Chan MS, Bradley M, Bundy DAP. Transmission patterns and the epidemiology of hookworm infection. Int. J. Epidemiol. 26(6), 1392-1400 (1997).
24. Bergquist NR, Leonardo LR, Mitchell GF. Vaccine-linked chemotherapy: can schistosomiasis control benefit from an integrated approach? Trends Parasitol. 21(3), 112-117 (2005). • Introduces the concept of vaccine-linked chemotherapy.
25. Mountford AP, Harrop R. Vaccination against schistosomiasis: the case for lung-stage antigens. Parasitol. Today 14(3), 109-114 (1998).
26. Miller TA. Vaccination against the canine hookworm diseases. Adv. Parasitol. 9, 155-183 (1971).
27. Kasschau MR, Dresden MH. Schistosoma mansoni: characterization of hemolytic activity from adult worms. Exp. Parasitol. 61(2), 201-209 (1986).
28. Don TA, Jones MK, Smyth D, O'Donoghue P, Hotez P, Loukas A. A poreforming haemolysin from the hookworm, Ancylostoma caninum. Int. J. Parasitol. 34(9), 1029-1035 (2004).
29. Morales ME, Rinaldi G, Kines KJ, Gobert GN, Tort JF, Brindley PJ. RNA interference targeting Schistosoma mansoni cathepsin D, the apical enzyme of the hemoglobin proteolysis cascade. Mol. Biochem. Parasitol. 157(2), 160-168 (2008).
30. Williamson AL, Lecchi P, Turk BE et al. A multi-enzyme cascade of hemoglobin proteolysis in the intestine of blood-feeding hookworms. J. Biol. Chem. 279(34), 35950-35957 (2004).
31. Brooker S, Jardim-Botelho A, Quinnell RJ et al. Age-related changes in hookworm infection, anaemia and iron deficiency in an area of high Necator americanus hookworm transmission in south-eastern Brazil. Trans. R. Soc. Trop. Med. Hyg. 101(2), 146-154 (2007).
32. Raso G, Vounatsou P, Singer BH, N'Goran EK, Tanner M, Utzinger J. An integrated approach for risk profiling and spatial prediction of Schistosoma mansoni-hookworm coinfection. Proc. Natl Acad. Sci. USA 103(18), 6934-6939 (2006). • Contributes to the evidence base for hookworm-schistosome coinfection.
33. Fleming FM, Brooker S, Geiger SM et al. Synergistic associations between hookworm and other helminth species in a rural community in Brazil. Trop. Med. Int. Health 11(1), 56-64 (2006). • Contributes to the evidence base for hookworm-schistosome coinfection.
34. Lwambo NJS, Siza JE, Brooker S, Bundy DAP, Guyatt H. Patterns of concurrent hookworm infection and schistosomiasis in schoolchildren in Tanzania. Trans. R. Soc. Trop. Med. Hyg. 93(5), 497-502 (1999).
35. Tchuem Tchuente L-A, Behnke JM, Gilbert FS, Southgate VR, Vercruysse J. Polyparasitism with Schistosoma haematobium and soil-transmitted helminth infections among school children in Loum, Cameroon. Trop. Med. Int. Health 8(11), 975-986 (2003).
36. Ezeamama AE, Friedman JF, Olveda RM et al. Functional significance of low-intensity polyparasite helminth infections in anemia. J. Infect. Dis. 192(12), 2160-2170 (2005). • Emphasizes anemia as a common end-point pathology.
37. Brito LL, Barreto ML, Silva RDCR et al. Moderate- and low-intensity co-infections by intestinal helminths and Schistosoma mansoni, dietary iron intake, and anemia in Brazilian children. Am. J. Trop. Med. Hyg. 75(5), 939-944 (2006).
38. Bergquist NR, Colley DG. Schistosomiasis vaccine: research to development. Parasitol. Today 14(3), 99-104 (1998).
39. Braschi S, Wilson RA. Proteins exposed at the adult schistosome surface revealed by biotinylation. Mol. Cell. Proteomics 5(2), 347-356 (2006).
40. Tran MH, Pearson MS, Bethony JM et al. Tetraspanins on the surface of Schistosoma mansoni are protective antigens against schistosomes. Nat. Med. 12(7), 835-840 (2006).
41. Bethony JM, Simon G, Diemert DJ et al. Randomized, placebo-controlled, double-blind trial of the Na-ASP-2 hookworm vaccine in unexposed adults. Vaccine 26(19), 2408-2417 (2008). • First published report of a Phase I study of a human helminth vaccine.
42. Hotez PJ, Molyneux DH, Fenwick A et al. Control of neglected tropical diseases. N. Engl. J. Med. 357(10), 1018-1027 (2007). • Outlines the global health importance of helminth infections and other neglected tropical diseases and the opportunity for their global control.
43. Hotez PJ, Ferris M. The antipoverty vaccines. Vaccine 24(31-32), 5787-5799 (2006). • Summarizes the role of anthelminthic vaccines for achieving the Millenium Development Goals.
44. Capron A, Riveau G, Capron M, Trottein F. Schistosomes: the road from host-parasite interactions to vaccines in clinical trials. Trends Parasitol. 21(3), 143-149 (2005).
45. Utzinger J, Zhou XN, Chen MG, Bergquist R. Conquering schistsosomiasis in China: the long march. Acta Trop. 96 (2-3), 69-96 (2005).